Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies

Little is known about COVID-19 mRNA vaccine humoral immune responses in patients with central nervous system autoimmune demyelinating diseases, multiple sclerosis (MS) and neuromyelitis optica (NMO), who are on B-cell depleting therapies (BCDT) and other disease modifying therapies (DMTs). We conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Ahya, Dwyer, Deanna, Wu, Qi, Wang, Qin, Dowling, Catherine A., Fox, David A., Khanna, Dinesh, Poland, Gregory A., Mao-Draayer, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411370/
https://www.ncbi.nlm.nih.gov/pubmed/34483021
http://dx.doi.org/10.1016/j.vaccine.2021.08.078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411370/
https://www.ncbi.nlm.nih.gov/pubmed/34483021
http://dx.doi.org/10.1016/j.vaccine.2021.08.078

Ejemplares similares